Johnson & Johnson Begins Late-Stage Coronavirus Vaccine Trial Unlisted Video

Coronavirus deaths have surpassed 206,000 in the U.S as the world awaits a vaccine.
Business Inisder reports that Johnson & Johnson has started a late-stage trial for its coronavirus vaccine.
The 60,000-person trial will be conducted to test the safety and efficacy of the experimental vaccine.
Johnson & Johnson is one of a number of pharmaceutical companies testing vaccines for the deadly virus.
The U.S. has reported the most cases of COVID-19 in the world with over 7 million since the beginning of the pandemic.
Experts are hopeful to have an effective vaccine by spring 2021.